GENEVA, Aug. 6 -- MEDIAR THERAPEUTICS, INC. (20 Overland Street, Suite 520Boston, Massachusetts 02215) filed a patent application (PCT/US2025/012958) for "THERAPEUTIC ANTIBODY TARGETING WISP1 PROTEIN" on Jan 24, 2025. With publication no. WO/2025/160400, the details related to the patent application was published on Jul 31, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): YAWORSKY, Paul (c/o MEDIAR THERAPEUTICS, INC.Boston, Massachusetts 02215), ESPELIN, Christopher (c/o MEDIAR THERAPEUTICS, INC.Boston, Massachusetts 02215), TAVARES, Daniel (c/o MEDIAR THERAPEUTICS, INC.Boston, Massachusetts ...